Second, it was detected that rectal insulin instillation in colitis-active phase significantly exacerbated colitis, suggesting that rectal insulin instillation should be forbidden during acute-colitis phase of IBD, which complements the deficiencies of previous studies. This evidence concerns the gene INS and inflammatory bowel disease.